S 252
115th Congress
Senate
Health
Government information and archives
Health care costs and insurance
Inflation and prices
Medicaid
Medicare
Prescription drugs
Public contracts and procurement
Retail and wholesale trades
Medicare Drug Savings Act of 2017
Introduced: February 1, 2017
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 1, 2017
Read twice and referred to the Committee on Finance.
Feb 1, 2017
Introduced in Senate
Plain-English summary
Medicare Drug Savings Act of 2017
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1